<?xml version='1.0' encoding='UTF-8' standalone='yes'?>
<rss version="2.0">
  <channel>
    <title>Medizinische Genetik</title>
    <link>www.degruyter.com</link>
    <description/>
    <item>
      <title>Frontmatter</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-frontmatter1/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-frontmatter1/html</guid>
    </item>
    <item>
      <title>Newborn screening in Germany</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2119/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2119/html</guid>
    </item>
    <item>
      <title>Legal aspects of newborn screening</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2110/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2110/html</guid>
    </item>
    <item>
      <title>From newborn screening to genomic medicine: challenges and suggestions on how to incorporate genomic newborn screening in public health programs</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2113/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2113/html</guid>
    </item>
    <item>
      <title>Second-tier strategies in newborn screening – potential and limitations</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2117/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2117/html</guid>
    </item>
    <item>
      <title>Twenty years of newborn screening for congenital adrenal hyperplasia and congenital primary hypothyroidism – experiences from the DGKED/AQUAPE study group for quality improvement in Germany</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2114/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2114/html</guid>
    </item>
    <item>
      <title>Population-based screening in children for early diagnosis and treatment of familial hypercholesterolemia: design of the VRONI study</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2115/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2115/html</guid>
    </item>
    <item>
      <title>S1-Leitlinie: Tumorgenetik – Diagnostik im Kontext maligner Erkrankungen</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2112/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2112/html</guid>
    </item>
    <item>
      <title>Jahresberichte 2021 aus den GfH-Kommissionen und GfH-Arbeitskreisen</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2118/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2118/html</guid>
    </item>
    <item>
      <title>Über die Notwendigkeit der Anerkennung von sog. Kernberufsgruppen innerhalb der genetischen Gesundheitsversorgung in Europa</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2116/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2116/html</guid>
    </item>
    <item>
      <title>GenomDE und Modellvorhaben – neue Versorgungsstrukturen in der Humangenetik</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2111/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2111/html</guid>
    </item>
    <item>
      <title>Aktuelle Nachrichten</title>
      <link>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2120/html</link>
      <guid>https://www.degruyter.com/document/doi/10.1515/medgen-2022-2120/html</guid>
    </item>
  </channel>
</rss>
